Extensive pleural and pericardial effusion in chronic myeloid leukemia during treatment with dasatinib at 100 mg or 50 mg daily

Extensive pleural and pericardial effusion in chronic myeloid leukemia during treatment with dasatinib at 100 mg or 50 mg daily

Item
http://www.wikidata.org/entity/Q34451624
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.Severe thrombocytopenia after dasatinib treatment in a patient with Philadelphia chromosome-positive chronic myeloid leukemia.The role of dasatinib in the management of chronic myeloid leukemiaA Case of Dasatinib-Induced Hemorrhagic Colitis Diagnosed by the Lymphocyte Transformation Test in a Chronic Myeloid Leukemia Patient.Dasatinib inhibits actin fiber reorganization and promotes endothelial cell permeability through RhoA-ROCK pathwayDasatinib Induced Cardiac Tamponade-A Rare Association.Pleural and pericardial effusions in chronic myeloid leukemia patients receiving low-dose dasatinib therapy.The incidence of pleural and pericardial effusion is not higher in patients receiving dasatinib at low doses. (Reply).Severe adverse events associated with the use of second-line BCR/ABL tyrosine kinase inhibitors: preferential occurrence in patients with comorbidities.Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia.On the safety of low-dose dasatinib in comorbid and non-comorbid patients: what is real-life? (Reply).Comprehensive review of cardiovascular toxicity of drugs and related agents.Glucocorticosteroids rescue basophils from dasatinib-augmented immunoglobulin E-mediated histamine release.Is there something wrong in paradise? Christian beliefs and the safety of novel BCR/ABL1 inhibitors.
P2860

Extensive pleural and pericardial effusion in chronic myeloid leukemia during treatment with dasatinib at 100 mg or 50 mg daily

Item
http://www.wikidata.org/entity/Q34451624
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Extensive pleural and pericard ...... tinib at 100 mg or 50 mg daily
@ast
Extensive pleural and pericard ...... tinib at 100 mg or 50 mg daily
@en
Extensive pleural and pericard ...... tinib at 100 mg or 50 mg daily
@nl
type
label
Extensive pleural and pericard ...... tinib at 100 mg or 50 mg daily
@ast
Extensive pleural and pericard ...... tinib at 100 mg or 50 mg daily
@en
Extensive pleural and pericard ...... tinib at 100 mg or 50 mg daily
@nl
prefLabel
Extensive pleural and pericard ...... tinib at 100 mg or 50 mg daily
@ast
Extensive pleural and pericard ...... tinib at 100 mg or 50 mg daily
@en
Extensive pleural and pericard ...... tinib at 100 mg or 50 mg daily
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Extensive pleural and pericard ...... tinib at 100 mg or 50 mg daily
@en
P2093
P2860
P304
P31
P356
10.3324/HAEMATOL.2010.030494
P433
P478
P50
P577
P5875
P698
P921
P932